Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 2364317, 9 pages
http://dx.doi.org/10.1155/2016/2364317
Research Article

The In Vitro Lipolysis of Lipid-Based Drug Delivery Systems: A Newly Identified Relationship between Drug Release and Liquid Crystalline Phase

1State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau
2School of Health Sciences, Macao Polytechnic Institute, Macau
3Pharmacy Department, Wuhan Medical Treatment Center, Wuhan, China

Received 7 October 2015; Revised 4 February 2016; Accepted 4 February 2016

Academic Editor: René Holm

Copyright © 2016 Lu Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Pouton, “Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems,” European Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. S93–S98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. C. W. Pouton, “Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system,” European Journal of Pharmaceutical Sciences, vol. 29, no. 3-4, pp. 278–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. H. Porter, C. W. Pouton, J. F. Cuine, and W. N. Charman, “Enhancing intestinal drug solubilisation using lipid-based delivery systems,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 673–691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. W. Pouton and C. J. H. Porter, “Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 625–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. T. Larsen, P. Sassene, and A. Müllertz, “In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems,” International Journal of Pharmaceutics, vol. 417, no. 1-2, pp. 245–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. J. MacGregor, J. K. Embleton, J. E. Lacy et al., “Influence of lipolysis on drug absorption from the gastro-intestinal tract,” Advanced Drug Delivery Reviews, vol. 25, no. 1, pp. 33–46, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Müllertz, D. G. Fatouros, J. R. Smith, M. Vertzoni, and C. Reppas, “Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo,” Molecular Pharmaceutics, vol. 9, no. 2, pp. 237–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Kossena, W. N. Charman, B. J. Boyd, and C. J. H. Porter, “Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug,” Journal of Pharmaceutical Sciences, vol. 94, no. 3, pp. 481–492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. G. Fatouros, B. Bergenstahl, and A. Mullertz, “Morphological observations on a lipid-based drug delivery system during in vitro digestion,” European Journal of Pharmaceutical Sciences, vol. 31, no. 2, pp. 85–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Sek, C. J. H. Porter, and W. N. Charman, “Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 25, no. 3-4, pp. 651–661, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Kaukonen, B. J. Boyd, C. J. H. Porter, and W. N. Charman, “Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations,” Pharmaceutical Research, vol. 21, no. 2, pp. 245–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Kaukonen, B. J. Boyd, W. N. Charman, and C. J. H. Porter, “Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids,” Pharmaceutical Research, vol. 21, no. 2, pp. 254–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Mun, E. A. Decker, and D. J. McClements, “Influence of emulsifier type on in vitro digestibility of lipid droplets by pancreatic lipase,” Food Research International, vol. 40, no. 6, pp. 770–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. G. Fatouros, I. Walrand, B. Bergenstahl, and A. Müllertz, “Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products,” Pharmaceutical Research, vol. 26, no. 2, pp. 361–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Staggers, O. Hernell, R. J. Stafford, and M. C. Carey, “Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings,” Biochemistry, vol. 29, no. 8, pp. 2028–2040, 1990. View at Google Scholar · View at Scopus
  16. O. Hernell, J. E. Staggers, and M. C. Carey, “Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings,” Biochemistry, vol. 29, no. 8, pp. 2041–2056, 1990. View at Google Scholar · View at Scopus
  17. A. Christiansen, T. Backensfeld, and W. Weitschies, “Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes,” European Journal of Pharmaceutical Sciences, vol. 41, no. 2, pp. 376–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Dressman, M. Vertzoni, K. Goumas, and C. Reppas, “Estimating drug solubility in the gastrointestinal tract,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 591–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. A. Kossena, B. J. Boyd, C. J. H. Porter, and W. N. Charman, “Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs,” Journal of Pharmaceutical Sciences, vol. 92, no. 3, pp. 634–648, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Cuiné, W. N. Charman, C. W. Pouton, G. A. Edwards, and C. J. H. Porter, “Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs,” Pharmaceutical Research, vol. 24, no. 4, pp. 748–757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Alliet and E. Eggermont, “Watching fat digestion: a microscopic method assessing intraluminal lipolysis,” Acta Gastro-Enterologica Belgica, vol. 53, no. 5-6, pp. 472–478, 1990. View at Google Scholar · View at Scopus
  22. J. S. Patton and M. C. Carey, “Watching fat digestion,” Science, vol. 204, no. 4389, pp. 145–148, 1979. View at Google Scholar
  23. B. J. Boyd, S.-M. Khoo, D. V. Whittaker, G. Davey, and C. J. H. Porter, “A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats,” International Journal of Pharmaceutics, vol. 340, no. 1-2, pp. 52–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Kossena, W. N. Charman, B. J. Boyd, D. E. Dunstan, and C. J. H. Porter, “Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach,” Journal of Pharmaceutical Sciences, vol. 93, no. 2, pp. 332–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. H. Porter and W. N. Charman, “Intestinal lymphatic drug transport: an update,” Advanced Drug Delivery Reviews, vol. 50, no. 1-2, pp. 61–80, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Patton, R. D. Vetter, M. Hamosh, B. Borgstrm, M. Lindstrm, and M. C. Carey, “The light microscopy of triglyceride digestion,” Food Microstructure, vol. 4, no. 1, pp. 29–42, 1985. View at Google Scholar
  27. N. Garti, M. Avrahami, and A. Aserin, “Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution,” Journal of Colloid and Interface Science, vol. 299, no. 1, pp. 352–365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Fanun, “Structure probing of water/mixed nonionic surfactants/caprylic-capric triglyceride system using conductivity and NMR,” Journal of Molecular Liquids, vol. 133, no. 1–3, pp. 22–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Podlogar, M. Bešter Rogač, and M. Gašperlin, “The effect of internal structure of selected water-Tween 40®-Imwitor 308®-IPM microemulsions on ketoprofene release,” International Journal of Pharmaceutics, vol. 302, no. 1-2, pp. 68–77, 2005. View at Publisher · View at Google Scholar · View at Scopus